Cohen & Steers Income Opportunities REIT, Inc. ("CNSREIT") announced today its acquisition of Bridgepointe Shopping Center, an open-air community shopping center in San Mateo, California. The ...

Polaris Capital Management, an investment management company, released its third quarter 2024 investor letter. A copy of the ...

Last year around this time, several leading drugmakers announced significant M&A deals to help fill their pipelines, including Bristol-Myers Squibb's (BMY) proposed takeovers of Karuna and RayzeBio, ...

“But teaming with Erik De Clercq, a doctor from Leuven, Belgium who is still alive, and later with John Martin, who ...

This growth, in large part driven by tech and the continuing AI revolution, has surprised value investors and professional ...

Biotech giant Gilead Sciences, Inc. GILD has put up a steady performance in 2024 amid a volatile market. Its shares have ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

Note to readers: The Daily Edition will not be published Dec. 23 through Jan. 1. Look for it again in your inbox on Jan. 2.

The cyberattack happened earlier this year, the company disclosed. Other industry news comes from CVS, Gilead, Ionis, and more.

The global cardiometabolic drugs market is projected to grow from US$ 50 billion in 2021 to over US$ 70 billion by 2032, with a CAGR of 4% to 5%. Sales are expected to surpass US$ 55 billion by 2022, ...

Gilead Sciences will no longer provide four HIV medicines for free as part of a patient assistance program starting at the ...

BofA Securities has recently resumed Gilead Sciences, Inc. (GILD) stock to Buy rating, as announced on December 10, 2024, according to Finviz. Earlier, on November 15, 2024, Wolfe Research had ...